febuxostat has been researched along with Body Weight in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Fujishiro, M; Inoue, MK; Kikuchi, T; Kushiyama, A; Masaki, T; Matsunaga, Y; Mizuno, Y; Morii, K; Nakatsu, Y; Ono, H; Sakoda, H; Sasaki, K; Takahashi, M; Ueda, K; Yamamotoya, T | 1 |
| Johansson, S; Leander, J; Rekić, D | 1 |
| Adachi, T; Kanamura, N; Kobara, M; Nakata, T; Nessa, N; Pezzotti, G; Toba, H; Yamamoto, T | 1 |
| Morcos, GNB; Nadwa, EH; Salama, NM; Shafik, AN | 1 |
| Echizen, H; Hirai, T; Itoh, T; Kimura, T | 1 |
| Elkashef, WF; Heikal, MM; Ibrahim, TM; Shaaban, AA | 1 |
| Busso, N; Ives, A; Kobayashi, T; Matsui, C; Nomura, J; Shirakura, T; So, A; Tamura, M; Tsujimoto, S; Yamanaka, Y | 1 |
| Arava, S; Arya, DS; Bharti, S; Bhatia, J; Golechha, M; Krishnamurthy, B; Nag, TC; Rani, N; Ray, R | 1 |
| Hamlin, RL; Kijtawornrat, A; Lolly, JL; Roche, BM; Shemanski, D; Wessale, JL; Zhao, L | 1 |
| Avila-Casado, C; Bautista-García, P; Franco, M; Johnson, RJ; Nakagawa, T; Sánchez-Lozada, LG; Soto, V; Tapia, E; Vega-Campos, IP; Zhao, L | 1 |
10 other study(ies) available for febuxostat and Body Weight
| Article | Year |
|---|---|
Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chemokine CCL2; Collagen; Diabetic Nephropathies; Febuxostat; Glucose Intolerance; Hyperglycemia; Hyperuricemia; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Obese; Oxidative Stress; Peptide Fragments; Uric Acid; Xanthine Oxidase | 2019 |
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight.
Topics: Body Weight; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male | 2021 |
Febuxostat Attenuates the Progression of Periodontitis in Rats.
Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Blood Pressure; Body Weight; Disease Models, Animal; Febuxostat; Gingiva; Insulin Resistance; Interleukin-1beta; Ligation; Male; Osteoclasts; Osteoprotegerin; Oxidative Stress; Periodontitis; Rats, Wistar; Tumor Necrosis Factor-alpha; X-Ray Microtomography; Xanthine Dehydrogenase | 2021 |
Comparing the Effects of Febuxostat and Allopurinol in an Animal Model of Metabolic Syndrome.
Topics: Allopurinol; Animals; Blood Glucose; Blood Pressure; Body Weight; Catalase; Disease Models, Animal; Febuxostat; Glutathione Peroxidase; Insulin Resistance; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Xanthine Oxidase | 2021 |
Evaluation of a pharmacokinetic-pharmacodynamic model for hypouricaemic effects of febuxostat using datasets obtained from real-world patients.
Topics: Adult; Aged; Body Weight; Comorbidity; Datasets as Topic; Diabetes Mellitus; Dose-Response Relationship, Drug; Febuxostat; Female; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Models, Biological; Sodium Potassium Chloride Symporter Inhibitors; Treatment Outcome; Uric Acid; Xanthine Oxidase | 2018 |
Effect of febuxostat on biochemical parameters of hyperlipidemia induced by a high-fat diet in rabbits.
Topics: Animals; Biomarkers; Body Weight; Cell Adhesion Molecules; Cytokines; Diet, High-Fat; Febuxostat; Hyperlipidemias; Lipids; Liver; Male; Oxidative Stress; Rabbits | 2019 |
Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Cholesterol; Cytokines; Disease Models, Animal; Endothelial Cells; Febuxostat; Gout Suppressants; Inflammation; L-Lactate Dehydrogenase; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Plaque, Atherosclerotic; Reactive Oxygen Species; Thiazoles; Xanthine Oxidase | 2014 |
Febuxostat ameliorates doxorubicin-induced cardiotoxicity in rats.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biomarkers; Body Weight; Doxorubicin; Febuxostat; Heart; Male; Organ Size; Rats; Rats, Wistar; Superoxide Dismutase; Thiazoles; Thiobarbituric Acid Reactive Substances; Xanthine Oxidase | 2015 |
Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
Topics: Allopurinol; Animals; Body Weight; Echocardiography; Enzyme Inhibitors; Febuxostat; Heart Failure; Male; Myocardial Infarction; Myocardium; Organ Size; Rabbits; Thiazoles; Time Factors; Xanthine Oxidase | 2008 |
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
Topics: Animals; Blood Pressure; Body Weight; Energy Intake; Febuxostat; Fructose; Gout Suppressants; Kidney; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Renal Circulation; Thiazoles; Xanthine Oxidase | 2008 |